癌旁交叉呈递给细胞毒性T淋巴细胞削弱肝细胞癌的免疫治疗效果, Huang CX, Lao XM, Wang XY, Ren YZ, Lu YT, Shi W, Wang YZ, Wu CY, Xu L, Chen MS, Gao Q, Liu L, Wei Y, Kuang DM, 2024
NK细胞引发的gasdermin-D依赖性肝细胞焦亡诱导中性粒细胞胞外陷阱,促进HBV相关的急性-慢性肝功能衰竭, Zhao Q, Chen DP, Chen HD, Wang YZ, Shi W, Lu YT, Ren YZ, Wu YK, Pang YH, Deng H, He X, Kuang DM, Guo ZY, 2024
miRNome靶向NF-κB信号协调巨噬细胞触发的癌症转移和复发, Chen DP, Wang JC, Liu ZY, Li PL, Chan KW, Wu XN, Yao WD, Yao T, Kuang DM, Wei Y, 2024
靶向铁死亡引发的炎症抑制肝细胞癌转移并增强索拉非尼疗效, Mu M, Huang CX, Qu C, Li PL, Wu XN, Yao W, Shen C, Huang R, Wan CC, Jian ZW, Zheng L, Wu RQ, Lao XM, Kuang DM, 2024
髓系细胞与B细胞之间的串扰塑造了原发性和继发性肝癌的不同微环境, Chen Z, Zhang G, Ren X, Yao Z, Zhou Q, Ren X, Chen S, Xu L, Sun K, Zeng Q, Kuang M, Kuang DM, Peng S, 2023
吉西他滨加顺铂治疗后鼻咽癌的肿瘤免疫微环境, Lv J, Wei Y, Yin JH, Chen YP, Zhou GQ, Wei C, Liang XY, Zhang Y, Zhang CJ, He SW, He QM, Huang ZL, Guan JL, Shen JY, Li XM, Li JY, Li WF, Tang LL, Mao YP, Guo R, Sun R, Zheng YH, Zhou WW, Xiong KX, Wang SQ, Jin X, Liu N, Li GB, Kuang DM, Sun Y, Ma J, 2023
免疫检查点治疗引发的IgG抗体唾液酸化削弱肝细胞癌中的抗肿瘤I型干扰素反应, Wu RQ, Lao XM, Chen DP, Qin H, Mu M, Cao WJ, Deng J, Wan CC, Zhan WY, Wang JC, Xu L, Chen MS, Gao Q, Zheng L, Wei Y, Kuang DM, 2023
靶向炎性巨噬细胞重建DOT1L抑制在肝细胞癌中的治疗效果, Yang YB, Wu CY, Wang XY, Deng J, Cao WJ, Tang YZ, Wan CC, Chen ZT, Zhan WY, Shan H, Kuang DM, Wei Y, 2023
促炎巨噬细胞诱导的PIM2表达抑制肝细胞癌中的免疫治疗效果, Wang JC, Chen DP, Lu SX, Chen JB, Wei Y, Liu XC, Tang YH, Zhang R, Chen JC, Kan A, Xu L, Zhang YJ, Hou J, Kuang DM, Chen MS, Zhou ZG, 2022
RNA解旋酶DDX24稳定LAMB1以促进肝细胞癌进展, Liu T, Gan H, He S, Deng J, Hu X, Li L, Cai L, He J, Long H, Cai J, Li H, Zhang Q, Wang L, Chen F, Chen Y, Zhang H, Li J, Yang L, Liu Y, Yang JH, Kuang DM, Pang P, He H, Shan H, 2022
c-Myc驱动的糖酵解极化功能性调节B细胞,触发致病性炎症反应, Wang XY, Wei Y, Hu B, Liao Y, Wang X, Wan WH, Huang CX, Mahabati M, Liu ZY, Qu JR, Chen XD, Chen DP, Kuang DM, Wang XH, Chen Y, 2022
B细胞通过ICOSL依赖的糖酵解极化致病性炎症T辅助亚群, Zeng QH, Wei Y, Lao XM, Chen DP, Huang CX, Lin QY, He M, Liao Y, Li B, Zheng L, Zhang GB, Chen Y, Kuang DM, 2020
单细胞转录组学揭示了与鼻咽癌预后相关的免疫细胞多样性和免疫亚型的调节因子, Chen YP, Yin JH, Li WF, Li HJ, Lv JW, Wang YQ, Chen DP, Zhang CJ, Li XM, Li JY, Zhang P, Li Y, He Q, Yang X, Lei Y, Tang LL, Zhou GQ, Mao YP, Wei C, Xiong KX, Zhang HB, Zhu SD, Hou Y, Sun Y, Dean M, Amit I, Wu K, Kuang DM, Li G, Liu N, Ma J, 2020
局部免疫景观决定肿瘤PD-L1异质性和对治疗的敏感性, Wei Y, Zhao Q, Gao Z, Lao XM, Lin WM, Chen DP, Mu M, Huang CX, Liu ZY, Li B, Zheng L, Kuang DM, 2019
肝细胞癌中浆细胞向免疫球蛋白G表型的极化涉及表观遗传改变并促进小鼠肝癌进展, Wei Y, Lao XM, Xiao X, Wang X, Wu ZJ, Zeng QH, Wu CY, Wu RQ, Chen ZX, Zheng L, Li B, Kuang DM, 2019
树突状细胞引发的B细胞激活通过IL-10信号在肝细胞癌中促进免疫特权, Ouyang FZ, Wu RQ, Wei Y, Liu RX, Yang D, Xiao X, Zheng L, Li B, Lao XM, Kuang DM, 2017
人类肝癌中组织驻留的TFH样细胞的极化桥接了先天性单核细胞炎症和M2b巨噬细胞极化, Chen MM, Xiao X, Lao XM, Wei Y, Liu RX, Zeng QH, Wang JC, Ouyang FZ, Chen DP, Chan KW, Shi DC, Zheng L, Kuang DM, 2016
PD-1hi识别出一种新型的调节性B细胞群体,在人类肝癌中促进疾病进展, Xiao X, Lao XM, Chen MM, Liu RX, Wei Y, Ouyang FZ, Chen DP, Zhao XY, Zhao Q, Li XF, Liu CL, Zheng L, Kuang DM, 2016
趋化因子(C-X-C基序)受体3阳性B细胞将白细胞介素-17炎症与人类肝细胞癌中的促肿瘤巨噬细胞极化联系起来, Liu RX, Wei Y, Zeng QH, Chan KW, Xiao X, Zhao XY, Chen MM, Ouyang FZ, Chen DP, Zheng L, Lao XM, Kuang DM, 2015
增加的自噬维持了人类肝细胞癌中中性粒细胞的生存和促肿瘤效应, Li XF, Chen DP, Ouyang FZ, Chen MM, Wu Y, Kuang DM, Zheng L, 2015
表达B7-H1的抗原呈递细胞介导促肿瘤Th22亚群的极化, Kuang DM, Xiao X, Zhao Q, Chen MM, Li XF, Liu RX, Wei Y, Ouyang FZ, Chen DP, Wu Y, Lao XM, Deng H, Zheng L, 2014
单核细胞/巨噬细胞引发的NK细胞功能障碍在肝细胞癌中通过CD48/2B4相互作用介导, Wu Y, Kuang DM, Pan WD, Wan YL, Lao XM, Wang D, Li XF, Zheng L, 2013
肿瘤周围中性粒细胞通过促进血管生成将炎症反应与疾病进展联系起来, Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, Yin XY, Zheng L, 2011
肝细胞癌肿瘤周围基质中的活化单核细胞促进记忆T辅助17细胞的扩增, Kuang DM, Peng C, Zhao Q, Wu Y, Chen M, Zheng L, 2010